X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
argon (5) 5
humans (4) 4
physics, applied (4) 4
physics, fluids & plasmas (4) 4
cell biology (3) 3
electrodes (3) 3
frequency (3) 3
index medicus (3) 3
ionization (3) 3
model (3) 3
pathology (3) 3
aceclofenac (2) 2
adult (2) 2
aged (2) 2
airtal (2) 2
alpha-adrenergic receptors (2) 2
animals (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antirheumatic agents - therapeutic use (2) 2
arrestins - metabolism (2) 2
arthritis, rheumatoid - drug therapy (2) 2
artrofoon (2) 2
beta-arrestins (2) 2
biomedicine (2) 2
biomedicine general (2) 2
cardiac-hypertrophy (2) 2
cell proliferation - drug effects (2) 2
dynamics (2) 2
efficacy (2) 2
electron-energy (2) 2
epidermal-growth-factor (2) 2
extracellular signal-regulated map kinases - metabolism (2) 2
female (2) 2
internal medicine (2) 2
kinases (2) 2
laboratory medicine (2) 2
male (2) 2
matrix metalloproteinases - metabolism (2) 2
medicine (2) 2
medicine, general & internal (2) 2
medicine, research & experimental (2) 2
middle aged (2) 2
non-specific low back pain (2) 2
non-steroidal anti-inflammatory drugs (2) 2
osteoarthritis (2) 2
pain (2) 2
phosphorylation (2) 2
plasma (2) 2
plasma applications (2) 2
plasma materials processing (2) 2
plasma sources (2) 2
protein-coupled receptors (2) 2
rats (2) 2
receptor, epidermal growth factor - metabolism (2) 2
receptors, adrenergic, alpha-1 - genetics (2) 2
research (2) 2
rheumatoid arthritis (2) 2
sheath (2) 2
signal transduction (2) 2
simulation (2) 2
src-family kinases - metabolism (2) 2
13.56 mhz (1) 1
acute coronary syndrome (1) 1
adrenergic alpha-1 receptor agonists - pharmacology (1) 1
adrenergic receptor (1) 1
adrenergic receptors (1) 1
alkali vapor (1) 1
alpha (1) 1
alpha-1-adrenergic receptors (1) 1
alterations (1) 1
anaferon (1) 1
anesthesiology (1) 1
angiotensin-ii (1) 1
antibodies - administration & dosage (1) 1
antibodies - therapeutic use (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
anticytokine therapy (1) 1
antirheumatic agents - administration & dosage (1) 1
antirheumatic agents - adverse effects (1) 1
ar/o-2 (1) 1
arbeitstemperatur (1) 1
arrestins - antagonists & inhibitors (1) 1
arrestins - genetics (1) 1
arterial blood-pressure (1) 1
artery-disease (1) 1
arthritis, rheumatoid - immunology (1) 1
article (1) 1
atmospheric modeling (1) 1
atmospheric-pressure argon (1) 1
beta-arrestin 1 (1) 1
blood pressure (1) 1
blood vessels (1) 1
brain research (1) 1
breakdown (1) 1
c-reactive protein (1) 1
caesium (1) 1
capacitively-coupled plasmas (1) 1
cardiac & cardiovascular systems (1) 1
cell cycle - drug effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Physics D: Applied Physics, ISSN 0022-3727, 01/2005, Volume 38, Issue 2, pp. 287 - 299
The parameters of a capacitively coupled plasma source operating in Xe/Ar mixtures have been studied using particle-in-cell/Monte Carlo methods. The plasma... 
PHYSICS, APPLIED | ELECTRON-ENERGY | ION ENERGY-DISTRIBUTION | RF DISCHARGE | FREQUENCY | MODEL | PARAMETERS | CROSS-SECTION | SHEATH | GLOW-DISCHARGE | MOBILITIES
Journal Article
2013 Abstracts IEEE International Conference on Plasma Science (ICOPS), ISSN 0730-9244, 06/2013, pp. 1 - 1
Summary form only given. Atmospheric-pressure microplasma jets are finding increasing use in biomedical applications to controllably deliver radical fluxes to... 
Electrodes | Atmospheric modeling | Ionization | Plasmas | Electron tubes | Helium | Argon
Conference Proceeding
Journal of Physics D: Applied Physics, ISSN 0022-3727, 10/2018, Volume 51, Issue 46, p. 464004
In this paper, results from the computational investigation of active species production in an argon microwave plasma torch are presented. We address the main... 
microwave argon plasma | feed gas | Plasma medicine | radicals production | DISCHARGE | PHYSICS, APPLIED | AR/O-2 | CHEMISTRY | DYNAMICS | JET | MODEL | plasma medicine | REMEDIATION
Journal Article
4. Full Text Poster session 3Cell growth, differentiation and stem cells - Heart511The role of the endocannabinoid system in modelling muscular dystrophy cardiac disease with induced pluripotent stem cells.512An emerging role of T lymphocytes in cardiac regenerative processes in heart failure due to dilated cardiomyopathy513Canonical wnt signaling reverses the ‘aged/senescent’ human endogenous cardiac stem cell phenotype514Hippo signalling modulates survival of human induced pluripotent stem cell-derived cardiomyocytes515Biocompatibility of mesenchymal stem cells with a spider silk matrix and its potential use as scaffold for cardiac tissue regeneration516A snapshot of genome-wide transcription in human induced pluripotent stem cell-derived hepatocyte-like cells (iPSC-HLCs)517Can NOS/sGC/cGK1 pathway trigger the differentiation and maturation of mouse embryonic stem cells (ESCs)?518Introduction of external Ik1 to human-induced pluripotent stem cell-derived cardiomyocytes via Ik1-expressing HEK293519Cell therapy of the heart studied using adult myocardial slices in vitro520Enhancement of the paracrine potential of human adipose derived stem cells when cultured as spheroid bodies521Mechanosensitivity of cardiomyocyte progenitor cells: the strain response in 2D and 3D environments522The effect of the vascular-like network on the maturation of the human induced pluripotent stem cell derived cardiomyocytes.Transcriptional control and RNA species - Heart525Gene expression regulation in heart failure: from pathobiology to bioinformatics526Human transcriptome in idiopathic dilated cardiomyopathy - a novel high throughput screening527A high-throghput approach unveils putative miRNA-mediated mitochondria-targeted cardioprotective circuits activated by T3 in the post ischemia reperfusion setting528The effect of uraemia on the expression of miR-212/132 and the calcineurin pathway in the rat heartCytokines and cellular inflammation - Heart531Lack of growth differentiation factor 15 aggravates adverse cardiac remodeling upon pressure-overload in mice532Blocking heteromerization of platelet chemokines ccl5 and cxcl4 reduces inflammation and preserves heart function after myocardial infarction533Is there an association between low-dose aspirin use and clinical outcome in HFPEF? Implications of modulating monocyte function and inflammatory mediator release534N-terminal truncated intracellular matrix metalloproteinase-2 expression in diabetic heart.535Expression of CD39 and CD73 on peripheral T-cell subsets in calcific aortic stenosis536Mast cells in the atrial myocardium of patients with atrial fibrillation: a comparison with patients in sinus rhythm539Characteristics of the inflammatory response in patients with coronary artery disease and arterial hypertension540Pro-inflammatory cytokines as cardiovascular events predictors in rheumatoid arthritis and asymptomatic atherosclerosis541Characterization of FVB/N murinic bone marrow-derived macrophage polarization into M1 and M2 phenotypes542The biological expression and thoracic anterior pain syndromeSignal transduction - Heart545The association of heat shock protein 90 and TGFbeta receptor I is involved in collagen production during cardiac remodelling in aortic-banded mice546Loss of the inhibitory GalphaO protein in the rostral ventrolateral medulla of the brainstem leads to abnormalities in cardiovascular reflexes and altered ventricular excitablitiy547Selenoprotein P regulates pressure overload-induced cardiac remodeling548Study of adenylyl cyclase activity in erythrocyte membranes in patients with chronic heart failure549Direct thrombin inhibitors inhibit atrial myocardium hypertrophy in a rat model of heart failure and atrial remodeling550Tissue factor / FVIIa transactivates the IGF-1R by a Src-dependent phosphorylation of caveolin-1551Notch signaling is differently altered in endothelial and smooth muscle cells of ascending aortic aneurysm patients552Frizzled 5 expression is essential for endothelial proliferation and migration553Modulation of vascular function and ROS production by novel synthetic benzopyran analogues in diabetes mellitusExtracellular matrix and fibrosis - Heart556Cardiac fibroblasts as inflammatory supporter cells trigger cardiac inflammation in heart failure557A role for galectin-3 in calcific aortic valve stenosis558Omega-3 polyunsaturated fatty acids- can they decrease risk for ventricular fibrillation?559Serum levels of elastin derived peptides and circulating elastin-antielastin immune complexes in sera of patients with coronary artery disease560Endocardial fibroelastosis is secondary to hemodynamic alterations in the chick model of hypoplastic left heart syndrome561Dynamics of serum levels of matrix metalloproteinases in primary anterior STEMI patients564Deletion of the alpha-7 nicotinic acetylcholine receptor changes the vascular remodeling induced by transverse aortic constriction in mice.565Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veinsIon channels, ion exchangers and cellular electrophysiology - Heart568Microtubule-associated protein RP/EB family member 1 modulates sodium channel trafficking and cardiac conduction569Investigation of electrophysiological abnormalities in a rabbit athlete's heart model570Upregulation of expression of multiple genes in the atrioventricular node of streptozotocin-induced diabetic rat571miR-1 as a regulator of sinoatrial rhythm in endurance training adaptation572Selective sodium-calcium exchanger inhibition reduces myocardial dysfunction associated with hypokalaemia and ventricular fibrillation573Effect of racemic and levo-methadone on action potential of human ventricular cardiomyocytes574Acute temperature effects on the chick embryonic heart functionVasculogenesis, angiogenesis and arteriogenesis577Clinical improvement and enhanced collateral vessel growth after monocyte transplantation in mice578The role of HIF-1 alpha, VEGF and obstructive sleep apnoea in the development of coronary collateral circulation579Initiating cardiac repair with a trans-coronary sinus catheter intervention in an ischemia/reperfusion porcine animal model580Early adaptation of pre-existing collaterals after acute arteriolar and venular microocclusion: an in vivo study in chick chorioallantoic membraneEndothelium583EDH-type responses to the activator of potassium KCa2.3 and KCa3.1 channels SKA-31 in the small mesenteric artery from spontaneously hypertensive rats584The peculiarities of endothelial dysfunction in patients with chronic renocardial syndrome585Endothelial dysfunction, atherosclerosis of the carotid arteries and level of leptin in patient with coronary heart disease in combination with hepatic steatosis depend from body mass index.586Role of non-coding RNAs in thoracic aortic aneurysm associated with bicuspid aortic valve587Cigarette smoke extract abrogates atheroprotective effects of high laminar flow on endothelial function588The prognostic value of anti-connective tissue antibodies in coronary heart disease and asymptomatic atherosclerosis589Novel potential properties of bioactive peptides from spanish dry-cured ham on the endothelium.Lipids592Intermediate density lipoprotein is associated with monocyte subset distribution in patients with stable atherosclerosis593The characteristics of dyslipidemia in rheumatoid arthritisAtherosclerosis596Macrophages differentiated in vitro are heterogeneous: morphological and functional profile in patients with coronary artery disease597Palmitoylethanolamide promotes anti-inflammatory phenotype of macrophages and attenuates plaque formation in ApoE-/- mice598Amiodarone versus esmolol in the perioperative period: an in vitro study of coronary artery bypass grafts599BMPRII signaling of fibrocytes, a mesenchymal progenitor cell population, is increased in STEMI and dyslipidemia600The characteristics of atherogenesis and systemic inflammation in rheumatoid arthritis601Role of adenosine-to-inosine RNA editing in human atherosclerosis602Presence of bacterial DNA in thrombus aspirates of patients with myocardial infarction603Novel E-selectin binding polymers reduce atherosclerotic lesions in ApoE(-/-) mice604Differential expression of the plasminogen receptor Plg-RKT in monocyte and macrophage subsets - possible functional consequences in atherogenesis605Apelin-13 treatment enhances the stability of atherosclerotic plaques606Mast cells are increased in the media of coronary lesions in patients with myocardial infarction and favor atherosclerotic plaque instability607Association of neutrophil to lymphocyte ratio with presence of isolated coronary artery ectasiaCalcium fluxes and excitation-contraction coupling610The coxsackie- and adenovirus receptor (CAR) regulates calcium homeostasis in the developing heart611HMW-AGEs application acutely reduces ICaL in adult cardiomyocytes612Measuring electrical conductibility of cardiac T-tubular systems613Postnatal development of cardiac excitation-contraction coupling in rats614Role of altered Ca2+ homeostasis during adverse cardiac remodeling after ischemia/reperfusion615Experimental study of sarcoplasmic reticulum dysfunction and energetic metabolism in failing myocardium associated with diabetes mellitusHibernation, stunning and preconditioning618Volatile anesthetic preconditioning attenuates ischemic-reperfusion injury in type II diabetic patients undergoing on-pump heart surgery619The effect of early and delayed phase of remote ischemic preconditioning on ischemia-reperfusion injury in the isolated hearts of healthy and diabetic rats620Post-conditioning with 1668-thioate leads to attenuation of the inflammatory response and remodeling with less fibrosis and better left ventricular function in a murine model of myocardial infarction621Maturation-related changes in response to ischemia-reperfusion injury and in effects of classical ischemic preconditioning and remote preconditioningMitochondria and energetics624Phase changes in myocardial mitochondrial respiration caused by hypoxic preconditioning or periodic hypoxic training625Desmin mutations depress mitochondrial metabolism626Methylene blue modulates mitochondrial function and monoamine oxidases-related ROS production in diabetic rat hearts627Doxorubicin modulates the real-time oxygen consumption rate of freshly isolated adult rat and human ventricular cardiomyocytesCardiomyopathies and fibrosis630Effects of genetic or pharmacologic inhibition of the ubiquitin/proteasome system on myocardial proteostasis and cardiac function631Suppression of Wnt signalling in a desmoglein-2 transgenic mouse model for arrhythmogenic cardiomyopathy632Cold-induced cardiac hypertrophy is reversed after thermo-neutral deacclimatization633CD45 is a sensitive marker to diagnose lymphocytic myocarditis in endomyocardial biopsies of living patients and in autopsies634Atrial epicardial adipose tissue derives from epicardial progenitors635Caloric restriction ameliorates cardiac function, sympathetic cardiac innervation and beta-adrenergic receptor signaling in an experimental model of post-ischemic heart failure636High fat diet improves cardiac remodelling and function after extensive myocardial infarction in mice637Epigenetic therapy reduces cardiac hypertrophy in murine models of heart failure638Imbalance of the VHL/HIF signaling in WT1+ Epicardial Progenitors results in coronary vascular defects, fibrosis and cardiac hypertrophy639Diastolic dysfunction is the first stage of the developing heart failure640Colchicine aggravates coxsackievirus B3 infection in miceArterial and pulmonary hypertension642Osteopontin as a marker of pulmonary hypertension in patients with coronary heart disease combined with chronic obstructive pulmonary disease643Myocardial dynamic stiffness is increased in experimental pulmonary hypertension partly due to incomplete relaxation644Hypotensive effect of quercetin is possibly mediated by down-regulation of immunotroteasome subunits in aorta of spontaneously hypertensive rats645Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension646A preclinical evaluation of the anti-hypertensive properties of an aqueous extract of Agathosma (Buchu)Biomarkers648The adiponectin level in hypertensive females with rheumatoid arthritis and its relationship with subclinical atherosclerosis649Markers for identification of renal dysfunction in the patients with chronic heart failure650cardio-hepatic syndromes in chronic heart failure: North Africa profile651To study other biomarkers that assess during myocardial infarction652Interconnections of apelin levels with parameters of lipid metabolism in hypertension patients653Plasma proteomics in hypertension: prediction and follow-up of albuminuria during chronic renin-angiotensin system suppression654Soluble RAGE levels in plasma of patients with cerebrovascular events
by Gowran, A and Kulikova, T and Lewis, FC and Foldes, G and Fuentes, L and Viiri, LE and Spinelli, V and Costa, A and Perbellini, F and Sid-Otmane, C and Bax, NAM and Pekkanen-Mattila, M and Schiano, C and Chaloupka, A and Forini, F and Sarkozy, M and De Jager, SCA and Vajen, T and Glezeva, N and Lee, H W and Golovkin, A and Kucera, T and Musikhina, NA and Korzhenkov, NP and Santuchi, M DE C and Munteanu, D and Garcia, RG and Ang, R and Usui, S and Kamilova, U and Jumeau, C and Aberg, M and Kostina, DA and Brandt, MM and Muntean, D and Lindner, D and Sadaba, R and Bacova, B and Nikolov, A and Sedmera, D and Ryabov, V and Neto, FP and Lynch, M and Portero, V and Kui, P and Howarth, FC and Gualdoni, A and Prorok, J and Diolaiuti, L and Vostarek, F and Wagner, M and Abela, MA and Nebert, C and Xiang, W and Kloza, M and Maslenko, A and Grechanyk, M and Bhattachariya, A and Morawietz, H and Babaeva, AR and Martinez Sanchez, SM and Krychtiuk, KA and Starodubova, J and Fiorelli, S and Rinne, P and Ozkaramanli Gur, D and Hofbauer, T and Stellos, K and Pinon, P and Tsoref, O and Thaler, B and Fraga-Silva, RA and Fuijkschot, WW and Shaaban, MNS and Matthaeus, C and Deluyker, D and Scardigli, M and Zahradnikova, A and Dominguez, A and Kondrat'eva, D and Sosorburam, T and Murarikova, M and Duerr, GD and Griecsova, L and Portnichenko, VI and Smolina, N and Duicu, OANA M and Elder, JM and Zaglia, T and Lorenzon, A and Ruperez, C and Woudstra, L and Suffee, N and De Lucia, C and Russell-Hallinan, A and Menendez-Montes, I and Kapelko, VI and Emmens, RW and Hetman, O and Van Der Laarse, WJ and ...
Cardiovascular Research, ISSN 0008-6363, 07/2016, Volume 111, Issue suppl 1, pp. S92 - S116
Journal Article
Cardiovascular Research, ISSN 0008-6363, 07/2014, Volume 103, Issue suppl 1, pp. S128 - S128
Journal Article
Cardiovascular Research, ISSN 0008-6363, 07/2014, Volume 103, Issue suppl 1, pp. S31 - S31
Journal Article
Cardiovascular Research, ISSN 0008-6363, 07/2014, Volume 103, Issue suppl 1, pp. S128 - S128
Journal Article
8. Full Text Poster session 2Morphogenetic mechanisms290MiR-133 regulates retinoic acid pathway during early cardiac chamber specification291Bmp2 regulates atrial differentiation through miR-130 during early heart looping formationDevelopmental genetics294Association of deletion allele of insertion/deletion polymorphism in alpha 2B adrenoceptor gene and hypertension with or without type 2 diabetes mellitus295Association of G1359A polymorphism of the endocannabinoid type 1 receptor (CNR1) with coronary artery disease (CAD) with type 2 diabetes mellitusCell growth, differentiation and stem cells - Vascular298Gamma-secretase inhibitor prevents proliferation and migration of ductus arteriosus smooth muscle cells: a role of Notch signaling in postnatal closure of ductus arteriosus299Mesenchymal stromal-like cells (MLCs) derived from induced pluripotent stem (iPS) cells: a promising therapeutic option to promote neovascularization300Sonic Hedgehog promotes mesenchymal stem cell differentiation to vascular smooth muscle cells in cardiovacsular disease301Proinflammatory cytokine secretion and epigenetic modification in endothelial cells treated LPS-GinfivalisCell death and apoptosis - Vascular304Mitophagy acts as a safeguard mechanism against human vascular smooth muscle cell apoptosis induced by atherogenic lipidsTranscriptional control and RNA species - Vascular307MicroRNA-34a role in vascular calcification308Local delivery of a miR-146a inhibitor utilizing a clinically applicable approach attenuates neointima formation after vascular injury309Long noncoding RNA landscape of hypoxic endothelial cells310Specific circulating microRNAs levels associate with hypertension, hyperglycemia and dysfunctional HDL in acute coronary syndrome patientsCytokines and cellular inflammation - Vascular313Phosphodiesterase5A up-regulation in vascular endothelium under pro-inflammatory conditions: a newly disclosed anti-inflammatory activity for the omega-3polyunsaturated aatty acid docosahexaenoic acid314Cardiovascular risk modifying with extra-low dose anticytokine drugs in rhematoid arthritis315Conversion of human M-CSF macrophages into foam cells reduces their proinflammatory responses to classical M1-polarizing activation316Lymphocytic myocarditis coincides with increased plaque inflammation and plaque hemorrhage in coronary arteries, facilitating myocardial infarction317Serum osteoprotegerin level predictsdeclined numerous of circulating endothelial- derived and mononuclear-derived progenitor cells in patients with metabolic syndromeGrowth factors and neurohormones - Vascular320Effect of gastrin-releasing peptide (GRP) on vascular inflammationSignal transduction - Heart323A new synthetic peptide regulates hypertrophy in vitro through means of the inhibition of nfkb324Inducible fibroblast-specific knockout of p38 alpha map kinase is cardioprotective in a mouse model of isoproterenol-induced cardiac hypertrophy325Regulation of beta-adrenoceptor-evoked inotropic responses by inhibitory G protein, adenylyl cyclase isoforms 5 and 6 and phosphodiesterases326Binding to RGS3 and stimulation of M2 muscarinic acetylcholine receptors modulates the substrate specificity of p190RhoGAP in cardiac myocytes327Cardiac regulation of post-translational modifications, parylation and deacetylation in LMNA dilated cardiomyopathy mouse model328Beta-adrenergic regulation of the b56delta/pp2a holoenzyme in cardiac myocytes through b56delta phosphorylation at serine 573Nitric oxide and reactive oxygen species - Vascular331Oxidative stress-induced miR-200c disrupts the regulatory loop among SIRT1, FOXO1 and eNOS332Antioxidant therapy prevents oxidative stress-induced endothelial dysfunction and Enhances Wound Healing333Morphological and biochemical characterization of red blood cell in coronary artery diseaseCytoskeleton and mechanotransduction - Heart336Novel myosin activator, JSH compounds, increased myocardial contractility without chronotropic effect in ratsExtracellular matrix and fibrosis - Vascular339Ablation of Toll-like receptor 9 causes cardiac rupture after myocardial infarction by attenuating proliferation and differentiation of cardiac fibroblasts340Altered vascular remodeling in the mouse hind limb ischemia model in Factor VII activating protease (FSAP) deficiencyVasculogenesis, angiogenesis and arteriogenesis343Pro-angiogenic effects of proly-hydroxylase inhibitors and their potential for use in a novel strategy of therapeutic angiogenesis for coronary total occlusion344Nrf2 drives angiogenesis in transcription-independent manner: new function of the master regulator of oxidative stress response345Angiogenic gene therapy, despite efficient vascular growth, is not able to improve muscle function in normoxic or chronically ischemic rabbit hindlimbs -role of capillary arterialization and shunting346Effect of PAR-1 inhibition on collateral vessel growth in the murine hind limb model347Quaking is a key regulator of endothelial cell differentiation, neovascularization and angiogenesis348"Emerging angiogenesis" in the chick chorioallantoic membrane (CAM). An in vivo study349Exosomes from cardiomyocyte progenitor cells and mesenchymal stem cells stimulate angiogenesis in vitro and in vivo via EMMPRINEndothelium352Reciprocal regulation of GRK2 and bradykinin receptor stimulation modulate Ca2+ intracellular level in endothelial cells353The roles of bone morphogenetic proteins 9 and 10 in endothelial inflammation and atherosclerosis354The contribution of GPR55 to the L-alpha-lysophosphatidylinositol-induced vasorelaxation in isolated human pulmonary arteries355The endothelial protective ACE inhibitor Zofenoprilat exerts anti-inflammatory activities through H2S production356A new class of glycomimetic drugs to prevent free fatty acid-induced endothelial dysfunction357Endothelial progenitor cells to apoptotic endothelial cell-derived microparticles ration differentiatesas preserved from reduced ejection fractionheart failure358Proosteogenic genes are activated in endothelial cells of patients with thoracic aortic aneurysm359Endothelin ETB receptors mediate relaxing responses to insulin in pericardial resistance arteries from patients with cardiovascular disease (CVD)Smooth muscle and pericytes362CX3CR1 positive myeloid cells regulate vascular smooth muscle tone by inducing calcium oscillations via activation of IP3 receptors363A novel function of PI3Kg on cAMP regulation, role in arterial wall hyperplasia through modulation of smooth muscle cells proliferation364NRP1 and NRP2 play important roles in the development of neointimal hyperplasia in vivo365Azithromycin induces autophagy in aortic smooth muscle cellsCoagulation, thrombosis and platelets368The real time in vivo evaluation of platelet-dependent aldosterone prothrombotic action in mice369Development of a method for in vivo detection of active thrombi in mice370The antiplatelet effects of structural analogs of the taurine chloramine371The influence of heparin anticoagulant drugs on functional state of human platelets372Regulation of platelet aggregation and adenosine diphosphate release by d dimer in acute coronary syndrome (in vitro study)Oxygen sensing, ischaemia and reperfusion375Sirtuin 5 mediates brain injury in a mouse model of cerebral ischemia-reperfusion376Abscisic acid: a new player in cardiomyocyte protection from ischaemia?377Protective effects of ultramicronized palmitoylethanolamide (PEA-um) in myocardial ischaemia and reperfusion injury in vivo378Identification of stem cell-derived cardiomyocytes using cardiac specific markers and additional testing of these cells in simulated ischemia/reperfusion system379Single-dose intravenous metformin treatment could afford significant protection of the injured rat kidney in an experimental model of ischemia-reperfusion380Cardiotoxicity of long acting muscarinic receptor antagonists used for chronic obstructive pulmonary disease381Dependence antioxidant potential on the concentration of amino acids382The impact of ischemia-reperfusion on physiological parameters,apoptosis and ultrastructure of rabbit myocardium with experimental aterosclerosisMitochondria and energetics385MicroRNA-1 dependent regulation of mitochondrial calcium uniporter (MCU) in normal and hypertrophied hearts386Mitochondrial homeostasis and cardioprotection: common targets for desmin and aB-crystallin387Overexpression of mitofusin-2 (Mfn2) and associated mitochondrial dysfunction in the diabetic heart388NO-dependent prevention of permeability transition pore (MPTP) opening by H2S and its regulation of Ca2+ accumulation in rat heart mitochondria389G protein coupled receptor kinase 2 (GRK2) is fundamental in recovering mitochondrial morphology and function after exposure to ionizing radiation (IR)Gender issues392Sex differences in pulmonary vascular control; focus on the nitric oxide pathwayAging395Heart failure with preserved ejection fraction develops when feeding western diet to senescence-accelerated mice396Cardiovascular markers as predictors of cognitive decline in elderly hypertensive patients397Changes in connexin43 in old rats with volume overload chronic heart failureGenetics and epigenetics400Calcium content in the aortic valve is associated with 1G>2G matrix metalloproteinase 1 polymorphism401Neuropeptide receptor gene s (NPSR1) polymorphism and sleep disturbances402Endothelin-1 gene Lys198Asn polymorphism in men with essential hypertension complicated and uncomplicated with chronic heart failure403Association of common polymorphisms of the lipoprotein lipase and pon1 genes with the metabolic syndrome in a sample of community participantsGenomics, proteomics, metabolomics, lipidomics and glycomics405Gene expression quantification using multiplexed color-coded probe pairs to determine RNA content in sporadic cardiac myxoma406Large-scale phosphorylation study of the type 2 diabetic heart subjected to ischemia / reperfusion injury407Transcriptome-based identification of new anti-inflammatory properties of the olive oil hydroxytyrosol in vascular endothelial cell under basal and proinflammatory conditions408Gene polymorphisms combinations and risk of myocardial infarctionComputer modelling, bioinformatics and big data411Comparison of the repolarization reserve in three state-of-the-art models of the human ventricular action potentialMetabolism, diabetes mellitus and obesity414Endothelial monocyte-activating polypeptide-II improves heart function in type -I Diabetes mellitus415Admission glucose level is independent predictor of impaired left ventricular function in patients with acute myocardial infarction: a two dimensional speckle-tracking echocardiography study416Association between biochemical markers of lipid profile and inflammatory reaction and stiffness of the vascular wall in hypertensive patients with abdominal obesity417Multiple common co-morbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress and myocardial stiffening418Investigating the cardiovascular effects of antiretroviral drugs in a lean and high fat/sucrose diet rat model of obesity419Statins in the treatment of non-alcoholic steatohepatitis (NASH). Our experience from a 2-year prospective study in Constanta County, Romania420Epicardial adipose tissue as a predictor of cardiovascular outcome in patients with ACS undergoing PCI?Arterial and pulmonary hypertension423Dependence between heart rhythm disorers and ID polymorphism of ACE gene in hypertensive patients424Molecular mechanisms underlying the beneficial effects of Urocortin 2 in pulmonary arterial hypertension425Inhibition of TGf-b axis and action of renin-angiotensin system in human ascending aorta aneurysms426Early signs of microcirculation and macrocirculation abnormalities in prehypertension427Vascular smooth muscle cell-expressed Tie-2 controls vascular tone428Cardiac and vascular remodelling in the development of chronic thrombo-embolic pulmonary hypertension in a novel swine modelBiomarkers431Arrhythmogenic cardiomyopathy: a new, non invasive biomarker432Can circulating microRNAs distinguish type 1 and type 2 myocardial infarction?433Design of a high-throughput multiplex proteomics assay to identify left ventricular diastolic dysfunction in diabetes434Monocyte-derived and P-selectin-carrying microparticles are differently modified by a low fat diet in patients with cardiovascular risk factors who will and who will not develop a cardiovascular event435Red blood cell distribution width assessment by polychromatic interference microscopy of thin films in chronic heart failure436Invasive and noninvasive evaluation of quality of radiofrequency-induced cardiac denervation in patients with atrial fibrillation437The effect of therapeutic hypothermia on the level of brain derived neurotrophic factor (BDNF) in sera following cardiopulmonary resustitation438Novel biomarkers to predict outcome in patients with heart failure and severe aortic stenosis439Biological factors linking depression and anxiety to cardiovascular disease440Troponins and myoglobin dynamic at coronary arteries graftingInvasive, non-invasive and molecular imaging443Diet composition effects on the genetic typing of the mouse ob mutation: a micro-ultrasound characterization of cardiac function, macro and micro circulation and liver steatosis444Characterization of pig coronary and rabbit aortic lesions using IV-OCT quantitative analysis: correlations with histologyGene therapy and cell therapy447Enhancing the survival and angiogenic potential of mouse atrial mesenchymal cells448VCAM-1 expression in experimental myocardial infarction and its relation to bone marrow-derived mononuclear cell retentionTissue engineering451Advanced multi layered scaffold that increases the maturity of stem cell-derived human cardiomyocytes452Response of engineered heart tissue to simulated ischemia/reperfusion in the presence of acute hyperglycemic conditions453Serum albumin hydrogels prevent de-differentiation of neonatal cardiomyocytes454A novel paintbrush technique for transfer of low viscosity ultraviolet light curable cyan methacrylate on saline immersed in-vitro sheep heart
by Garcia-Martinez, V and Lopez Sanchez, C and Hamed, W and Hsu, JH and Ferrer-Lorente, R and Alshamrani, Maryam and Pizzicannella, J and Vindis, C and Badi, I and Korte, L and Voellenkle, C and Niculescu, L S and Massaro, M and Babaeva, AR and Da Silva, F and Woudstra, L and Berezin, A and Bae, MK and Del Giudice, C and Bageghni, S A and Krobert, K and Levay, M and Vignier, N and Ranieri, A and Magenta, A and Orlandi, A and Porro, B and Jeon, E-S and Omori, Y and Herold, J and Barnett, G A and Grochot-Przeczek, A and Korpisalo, P and Deffge, C and Margariti, A and Rong, W and Maring, JA and Gambardella, J and Mitrofan, CG and Karpinska, O and Morbidelli, L and Wilkinson, FL and Kostina, AS and De Mey, J G R and Kumar, A and Lupieri, A and Pellet-Many, C and Stamatiou, R and Gromotowicz, A and Dickhout, A and Murina, M and Roka-Moiia, YM and Malinova, L and Diaz-Canestro, C and Vigliarolo, T and Cuzzocrea, S and Szantai, A and Medic, B and Cassambai, S and Korda, A and Revnic, C R and Borile, G and Diokmetzidou, A and Murfitt, L and Budko, A and Fiordelisi, A and De Wijs-Meijler, DPM and Gevaert, AB and Noriega De La Colina, A and Benes, J and Guillermo Solache Berrocal, GSB and Gafarov, V and Zhebel, VM and Prakaschandra, R and Stepien, E L and Smith, LE and Carluccio, MA and Timasheva, Y and Paci, M and Dorofeyeva, N A and Chimed, CH and Petelina, TI and Sorop, O and Genis, A and Parepa, I R and Tscharre, M and Krestjyaninov, MV and Maia-Rocha, C and Borges, L and Sasonko, M L and Kapel, SS and Stam, K and Sommariva, E and Stojkovic, S and O'reilly, J and Chiva-Blanch, G and Evtushenko, A and Skopal, J and Sunderland, N and Gegenava, T and ...
Cardiovascular Research, ISSN 0008-6363, 07/2016, Volume 111, Issue suppl 1, pp. S56 - S81
Journal Article
Terapevticheskii Arkhiv, ISSN 0040-3660, 2018, Volume 90, Issue 6, pp. 65 - 73
To identify factors affecting the effectiveness of NSAIDs in patients with OA and LBP. An observational study was conducted to evaluate the effectiveness of a... 
Efficacy | Aceclofenac | Non-specific low back pain | Airtal | Osteoarthritis | Non-steroidal anti-inflammatory drugs
Journal Article
TERAPEVTICHESKII ARKHIV, ISSN 0040-3660, 2018, Volume 90, Issue 6, pp. 65 - 73
Non-steroidal anti-inflammatory drugs (NSAIDs) are most popular medications for the treatment of pain in common musculoskeletal diseases such as osteoarthritis... 
KNEE | MANAGEMENT | LOW-BACK-PAIN | SAFETY | osteoarthritis | RISK | non-steroidal anti-inflammatory drugs | MEDICINE | efficacy | MEDICINE, GENERAL & INTERNAL | aceclofenac | non-specific low back pain | GENDER | RECURRENCE | Airtal
Journal Article
by Karpov, Yuri Aleksandrovich and Abbasova, Ev and Abdualimova, Mh and Abdullina, Ar and Abramova, Vv and Avdonina, Nm and Avilova, Ov and Agapova, Vv and Agoeva, Mb and Adamova, Ha and Adamian, Mm and Adelshina, Lr and Aznaurova, Nr and Aydashova, Na and Akimochkina, Ag and Aksenova, Na and Akulova, Na and Aleynik, On and Alexandrova, Vn and Alpaeva, Yu and Amerdzhanyan, Ys and Amichba, Gn and Ananicheva, Gv and Ananyeva, Aa and Andreev, An and Andreeva, Gv and Andreeva, Ov and Andriyasheva, Ta and Androsova, Ia and Anisimova, Ii and Anisimova, Nv and Anpalova, Ey and Antonova, Tg and Anoufriev, Dy and Aryukova, Av and Aslambekova, Fn and Astapenko, Ts and Astakhova, Ma and Afanasieva, Tn and Akhmetzyanova, Rr and Akhmetshina, Oa and Babaeva, Av and Baboshina, Ns and Baburenkova, Td and Baburina, Ni and Bagdulina, En and Badlina, An and Bakal, Op and Balaeva, Zv and Balakina, Vi and Balobina, Oi and Barannikova, Ia and Baranova, Sp and Bargueva, Sg and Bardash, Ga and Barinova, Tn and Batmanova, Ln and Batsoeva, As and Baccina, Tv and Belkina, N and Belkorei, Os and Belokopytova, Is and Bichunskaya, Va and Blinova, Ga and Blinova, Mn and Bobkova, Lv and Boboshko, Tn and Bogatova, Tk and Bogdanova, Va and Bogdanova, Ti and Bogdashkina, Yv and Bodrihin, Nv and Bolshakova, Tv and Bondareva, Ei and Bondar, Mn and Borodina, Ev and Botasheva, Tt and Bochkova, Yv and Boyarshinova, Ga and Bredneva, Ai and Bronnikova, Vv and Budanova, Ov and Buldakov, Im and Burlaka, Ap and Burljaeva, Ts and Burma, Vi and Burmina, El and Booth-Gusaim, Vi and Bydanova, Ss and Bykov, An and Bykova, Lv and Bylinaa, Ol and Bystrova, Ea and Vavilova, Va and Vavilova, Nv and Vagaytseva, Ea and Valieva, Gt and Valiullova, Gr and Varezhnikova, Ov and Varnakova, Ln and ...
Clinical Drug Investigation, ISSN 1173-2563, 09/2017, Volume 37, Issue 9, pp. 889 - 890
Journal Article
CARDIOVASCULAR THERAPY AND PREVENTION, ISSN 1728-8800, 2012, Volume 11, Issue 1, pp. 49 - 53
Aim. To assess the diagnostic value of immunological markers of endothelial dysfunction (ED) in various clinical variants of coronary heart disease (CHD).... 
C-REACTIVE PROTEIN | CARDIAC & CARDIOVASCULAR SYSTEMS | inflammation | PREDICTORS | ELEVATION | Acute coronary syndrome | immunological markers | ARTERY-DISEASE | acute coronary syndrome
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2015, Volume 10, Issue 11, p. e0142787
alpha(1a) Adrenergic receptors (alpha(1a)ARs) are the predominant AR subtype in human vascular smooth muscle cells (SMCs). alpha(1a)ARs in resistance vessels... 
SIGNAL-REGULATED KINASES | MULTIDISCIPLINARY SCIENCES | EPIDERMAL-GROWTH-FACTOR | CARDIAC-HYPERTROPHY | FACTOR RECEPTOR ACTIVATION | PROTEIN-COUPLED RECEPTORS | ARTERIAL BLOOD-PRESSURE | ALPHA-ADRENERGIC RECEPTORS | ENHANCES MMP-2 PRODUCTION | ANGIOTENSIN-II | MATRIX METALLOPROTEINASE-7 | Receptor, Epidermal Growth Factor - genetics | Muscle, Smooth, Vascular - metabolism | Humans | Transcriptional Activation - drug effects | Myocytes, Smooth Muscle - pathology | Rats | Extracellular Signal-Regulated MAP Kinases - metabolism | Arrestins - metabolism | Adrenergic alpha-1 Receptor Agonists - pharmacology | Genetic Variation | Receptor, Epidermal Growth Factor - metabolism | Animals | Signal Transduction - drug effects | Models, Biological | Receptors, Adrenergic, alpha-1 - genetics | beta-Arrestins | src-Family Kinases - metabolism | Cell Proliferation - drug effects | Matrix Metalloproteinases - metabolism | Phosphorylation - drug effects | Cell Cycle - drug effects | Hypertrophy | Fibroblasts | Smooth muscle | Genetic aspects | Research | Phosphorylation | Kinases | Modulators | Proteins | Signal transduction | Receptors | Epidermal growth factor | Pain | Rodents | Physiology | Blood pressure | Inhibition | Phenotypes | Epidermal growth factor receptors | Contractility | Muscles | Extracellular signal-regulated kinase | Blood vessels | siRNA | Insulin | Muscle contraction | Gelatinase A | Genetic variance | Inhibitors | Stem cells | Adrenergic receptors | Anesthesiology | Receptors (physiology)
Journal Article
Cellular Signalling, ISSN 0898-6568, 09/2014, Volume 26, Issue 9, pp. 1985 - 1997
The role of naturally occurring human α -Adrenergic Receptor (α AR) genetic variants associated with cardiovascular disorders is poorly understood. Here, we... 
Matrix metalloproteinases (MMPs) | Adrenergic receptor | Transactivation | Epidermal growth factor receptor (EGFR) | Genetic variant | G protein coupled receptors (GPCRs) | RENAL EPITHELIAL-CELLS | TYROSINE KINASE | PROTEIN-COUPLED RECEPTORS | CELL BIOLOGY | STAT3 ACTIVATION | ALPHA-1-ADRENERGIC RECEPTORS | EPIDERMAL-GROWTH-FACTOR | CARDIAC-HYPERTROPHY | ALPHA-ADRENERGIC RECEPTORS | RAT-HEART | EGF RECEPTOR | Receptors, Adrenergic, alpha-1 - metabolism | Phosphorylation | Humans | Transcriptional Activation | Arrestins - genetics | Receptors, Adrenergic, alpha-1 - chemistry | Extracellular Signal-Regulated MAP Kinases - metabolism | Arrestins - metabolism | Receptor, Epidermal Growth Factor - metabolism | Phenylephrine - pharmacology | src-Family Kinases - metabolism | Cell Line | Myoblasts, Cardiac - cytology | Signal Transduction | Dipeptides - pharmacology | Rats | Tyrphostins - pharmacology | Arrestins - antagonists & inhibitors | Animals | Receptors, Adrenergic, alpha-1 - genetics | beta-Arrestin 1 | beta-Arrestins | Matrix Metalloproteinases - chemistry | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Cell Proliferation - drug effects | Fibroblasts - cytology | Matrix Metalloproteinases - metabolism | Mutation | Quinazolines - pharmacology | Human | Cellular | Alterations | Pathways | Genetics | Kinases | Gene expression | Remodeling | Matrix metalloproteinase (MMP) | genetic variant | G protein coupled receptors (GPCR) | transactivation
Journal Article
Plasma Sources Science and Technology, ISSN 0963-0252, 2014, Volume 23, Issue 3, pp. 35011 - 15
Journal Article